THE Philippine Economic Zone Authority (PEZA) yesterday bared P900 million investments in pharmaceuticals.
Makers of Katinko, known for its line of topical pain relievers, eyes to invest as much as P400 million for the construction of two more facilities to expand its operations in Victoria Industrial Park in Tarlac as it ramps up its global exports.
Victoria Industrial Park, which was recently granted a registration as a pharmaceutical ecozone for its 29-hectare property in Barangay Baculong ,is planning to expand the area for phase two covering 30 hectares.
Tereso Panga, director-general of PEZA, yesterday announced NephroPlus of India, Asia’s largest dialysis network, plans to invest P500 million for the establishment of 200 clinics in the Philippines.
“We are encouraging NephroPlus to locate in ecozones near city centers,” Panga said.
Greenstone Pharmaceutical HK, Inc., makers of Katinko, has an existing factory in Victoria where it produces ingredients from raw materials sourced from Aeta farmers. These ingredients, made from= a special variety of ginger, lemon grass and citronella, are supplied to its three factories in Cavite.
Greenstone will build two more factories in Victoria to triple its capacity for internal and external medicines as well as cosmetics and body care.
The company intends to expand its product line to include more internal medicines and even food manufacturing.
Target markets for export are the United States and the European Union.
